300356.SZ Stock Analysis
30
Uncovered
EleFirst Science & Technology Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
EleFirst Science & Tech Co., Ltd. engages in the development, manufacture, and sale of intelligent information collection systems. The company is headquartered in Nanjing, Jiangsu and currently employs 478 full-time employees. The company went IPO on 2012-09-24. The firm is principally involved in the research, development, manufacture and sale of pharmaceutical products. The firm's main products include compound dichloroacetic acid diisopropylamine for injection, amifostine for injection, clindamycin phosphate for injection and urokinase for injection. The firm distributes its products in domestic market.